NanoCluster budesonide formulations enable efficient drug delivery driven by mechanical ventilation

International Journal of Pharmaceutics - Tập 462 - Trang 19-28 - 2014
Warangkana Pornputtapitak1, Nashwa El-Gendy1,2, Joel Mermis3, Amy O’Brien-Ladner3, Cory Berkland1,4
1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA
2Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-suef University, Egypt
3Department of Medicine Division of Pulmonary Diseases and Critical Care Medicine, University of Kansas Medical Center, Kansas City, KS, USA
4Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, KS, USA

Tài liệu tham khảo

Amirav, 2005, Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma, Pediatric Pulmonol., 39, 447, 10.1002/ppul.20180 Ari, 2010, Factors affecting bronchodilator delivery in mechanically ventilated adults, Nurs. Crit. Care, 15, 192, 10.1111/j.1478-5153.2010.00395.x Behara, S.R.B., Kippax, P., Larson, I., Morton, D.A.V., Stewart, P., 2011. Kinetics of emitted mass—a study with three dry powder inhaler devices. Chem. Eng. Sci. Behara, 2012, Insight into pressure drop dependent efficiencies of dry powder inhalers, Eur. J. Pharm. Sci., 10.1016/j.ejps.2012.02.019 Bowton, D.L., Hite, R.D., 2011. 2.3 Ventilator mechanics. Practical Guide to Mechanical Ventilation, 133. Broeders, 2001, Peak inspiratory flow rate and slope of the inhalation profiles in dry powder inhalers, Eur. Respir. J., 18, 780, 10.1183/09031936.01.00240301 BYRON, 1998, United States pharmacopeia recommendations for the testing of inhalers, J. Aerosol Med., 11, 11, 10.1089/jam.1998.11.Suppl_1.S-11 Casanova, 2005, Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med., 171, 591, 10.1164/rccm.200407-867OC Chavan, 2002, Novel system to investigate the effects of inhaled volume and rates of rise in simulated inspiratory air flow on fine particle output from a dry powder inhaler, AAPS J., 4, 7, 10.1208/ps040211 Chew, 2002, The role of particle properties in pharmaceutical powder inhalation formulations, J. Aerosol Med., 15, 325, 10.1089/089426802760292672 Chew, 2002, Characterization of pharmaceutical powder inhalers: estimation of energy input for powder dispersion and effect of capsule device configuration, J. Aerosol Sci., 33, 999, 10.1016/S0021-8502(02)00059-9 Coates, 2005, Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses, Pharm. Res., 22, 1445, 10.1007/s11095-005-6155-x Coates, 2005, The role of capsule on the performance of a dry powder inhaler using computational and experimental analyses, Pharm. Res., 22, 923, 10.1007/s11095-005-4587-y Dhand, 2007, Inhalation therapy in invasive and noninvasive mechanical ventilation, Curr. Opin. Crit. Care, 13, 27, 10.1097/MCC.0b013e328012e022 Dolovich, 2011, Aerosol drug delivery: developments in device design and clinical use, Lancet, 377, 1032, 10.1016/S0140-6736(10)60926-9 Dunbar, 1998, Dispersion and characterization of pharmaceutical dry powder aerosols, Kona, 16, 7, 10.14356/kona.1998007 El-Gendy, 2009, Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution, J. Pharm. Sci., 98, 2731, 10.1002/jps.21630 El-Gendy, 2012, Development of budesonide nanocluster dry powder aerosols: preformulation, J. Pharm. Sci., 101, 3434, 10.1002/jps.23197 EVERARD, 2000, CFC transition: the Emperor's new clothes. Each class of drug deserves a delivery system that meets its own requirements, Thorax, 55, 811, 10.1136/thorax.55.10.811 Everard, 1996, In vitro assessment of drug delivery through an endotracheal tube using a dry powder inhaler delivery system, Thorax, 51, 75, 10.1136/thx.51.1.75 Fink, 1996, Aerosol delivery from a metered-dose inhaler during mechanical ventilation. An in vitro model, Am. J. Respir. Crit. Care Med., 154, 382, 10.1164/ajrccm.154.2.8756810 Fink, 1999, Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inhaler during mechanical ventilation and defining efficiency-enhancing factors, Am. J. Res. Crit. Care Med., 159, 63, 10.1164/ajrccm.159.1.9803119 Georgopoulos, 2006, Bedside waveforms interpretation as a tool to identify patient-ventilator asynchronies, Intensive Care Med., 32, 34, 10.1007/s00134-005-2828-5 Haas, 2012, Advanced ventilator modes and techniques, Crit. Care Nurs. Quart., 35, 27, 10.1097/CNQ.0b013e31823b2670 Hess, 2003, In vitro evaluation of aerosol bronchodilator delivery during mechanical ventilation: pressure-control vs. volume control ventilation, Intensive Care Med., 29, 1145, 10.1007/s00134-003-1792-1 Labiris, 2003, Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications, Br. J. Clin. Pharmacol., 56, 600, 10.1046/j.1365-2125.2003.01893.x Lenney, 2000, Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices, Respir. Med., 94, 496, 10.1053/rmed.1999.0767 Louey, 2006, Standardized entrainment tubes for the evaluation of pharmaceutical dry powder dispersion, J. Aerosol Sci., 37, 1520, 10.1016/j.jaerosci.2006.04.002 Martonen, 2005, Issues in drug delivery: concepts and practice, Respir. Care, 50, 1228 Miller, 2003, Aerosol delivery and modern mechanical ventilation, Am. J. Respir. Crit. Care Med., 168, 1205, 10.1164/rccm.200210-1167OC Minne, 2008, Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients, Eur. J. Pharm. Biopharm., 70, 839, 10.1016/j.ejpb.2008.06.013 Mouloudi, 2000, Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern, Eur. Respir. J., 16, 263, 10.1034/j.1399-3003.2000.16b13.x Newman, 2002, Evolution of dry powder inhaler design, formulation, and performance, Respir. Med., 96, 293, 10.1053/rmed.2001.1276 Pornputtapitak, 2011, Nanocluster budesonide formulations enhance drug delivery through endotracheal tubes, J. Pharm. Sci. Ross, 1996, Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products, J. Aerosol Med., 9, 215, 10.1089/jam.1996.9.215 Sassoon, 2001, Patient-ventilator asynchrony, Curr. Opin. Crit. Care, 7, 28, 10.1097/00075198-200102000-00005 Srichana, 1998, Dry powder inhalers: the influence of device resistance and powder formulation on drug and lactose deposition in vitro, Eur. J. Pharm. Sci., 7, 73, 10.1016/S0928-0987(98)00008-6 Takaya, 2002, The efficiency of 2-agonist delivery through tracheal tubes with the metered-dose inhaler: an in vitro study, J. Anesthesia, 16, 284, 10.1007/s005400200044 Van Der Palen, 2003, Peak inspiratory flow through Diskus and Turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL®), Respir. Med., 97, 285, 10.1053/rmed.2003.1289 Zhu, 2008, Analysis of the influence of relative humidity on the moisture sorption of particles and the aerosolization process in a dry powder inhaler, J. Aerosol Sci., 39, 510, 10.1016/j.jaerosci.2008.02.003